Is Threshold Pharmaceuticals, Inc. (THLD) A Good Stock To Buy?

Seeing as Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) has faced a decline in interest from hedge fund managers, it’s safe to say that there were a few hedge funds who sold off their entire stakes by the end of the third quarter. At the top of the heap, First Eagle Investment Management dumped the biggest stake of the “upper crust” of funds watched by Insider Monkey, totaling close to $2 million in stock. Michael Castor’s fund, Sio Capital, also said goodbye to its stock, about $0.8 million worth.

Let’s now review hedge fund activity in other stocks similar to Threshold Pharmaceuticals, Inc. (NASDAQ:THLD). These stocks are Cogentix Medical Inc (NASDAQ:CGNT), MoSys Inc. (NASDAQ:MOSY), CAS Medical Systems Inc (NASDAQ:CASM), and Support.com, Inc. (NASDAQ:SPRT). This group of stocks’ market caps are similar to THLD’s market cap.

As you can see these stocks had an average of 4 hedge funds with bullish positions and the average amount invested in these stocks was $5 million. That figure was $5 million in THLD’s case. Cogentix Medical Inc (NASDAQ:CGNT) is the most popular stock in this table. On the other hand CAS Medical Systems Inc (NASDAQ:CASM) is the least popular one with only 3 bullish hedge fund positions. Compared to these stocks Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) is more popular among hedge funds. Considering that hedge funds are fond of this stock in relation to its market cap peers, it may be a good idea to analyze it in detail and potentially include it in your portfolio.

Disclosure: None